Real-life persistence of long-acting injectable antipsychotics in schizophrenic patients: A retrospective observational study in France .
CONCLUSION: PP demonstrated a significantly higher persistence rate than HD or R. Moreover, LAIA initiation with HD or R significantly increased the risk of treatment discontinuation relative to PP. Further comparative studies are required to comprehensively determine whether PP has a better efficacy and/or safety profile than other LAIs.
.
PMID: 31232279 [PubMed - as supplied by publisher]
Source: International Journal of Clinical Pharmacology and Therapeutics - Category: Drugs & Pharmacology Tags: Int J Clin Pharmacol Ther Source Type: research
More News: Drugs & Pharmacology | France Health | Invega | Invega Sustenna | Risperdal Consta | Schizophrenia | Study | Zyprexa